首页 > 最新文献

Journal of Gastrointestinal Surgery最新文献

英文 中文
First clinical report of the international single-port robotic rectal cancer registry 国际单端口机器人直肠癌登记处的第一份临床报告。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101929
John H. Marks , Hye Jin Kim , Gyu-Seog Choi , Luis Andres Idrovo , Suraj Chetty , Thais Reif De Paula , Deborah Keller
<div><h3>Background</h3><div>Rectal cancer surgery remains a significant technical challenge. The development and implementation of a new technology offer hope for more accurate and precise surgery. To evaluate whether single-port robotic (SPr) technology helps achieve this goal, an international SPr registry was established. This study reported short-term clinical and oncologic outcomes from an international SPr registry for rectal cancer.</div></div><div><h3>Methods</h3><div>A review of a prospective international registry of SPr technology approved for colorectal surgery with an investigational design exemption was conducted. Patients with rectal adenocarcinoma who had resection for curative intent using the SPr platform between November 2018 and September 2022 were included. Frequency statistics described patient and tumor characteristics and intraoperative, oncologic, and clinical outcome variables. The main outcome measure was the quality of the total mesorectal excision (TME) specimen. The secondary outcome measures were intraoperative conversion and 30-day postoperative morbidity and mortality.</div></div><div><h3>Results</h3><div>A total of 113 SPr procedures for rectal cancer were performed at 2 centers by 4 colorectal surgeons. Of note, 9 local excisions were excluded, leaving 104 cases analyzed. The cohort consisted of 53 men (50.96%), had a mean age of 60.00 years (SD, 11.29), and had a body mass index of 25.80 kg/m<sup>2</sup> (SD, 6.18). The most common T stage was 3 (55 [52.8%]), followed by 2 (19 [18.26%]). More than 60% of patients had preoperative neoadjuvant chemoradiation. The mean tumor distance from the anorectal ring was 2.90 cm (SD, 2.62), and the mean tumor size was 4.52 cm (SD, 1.82). The procedures performed included transanal abdominal transanal/transanal TME (52 [46%]), low anterior resection (49 [43.3%]), and abdominoperineal resection (3 [2.7%]). The mean operating time was 168.0 min (SD, 56.9). There were no intraoperative complications and 2 (1.9%) conversions to laparoscopy. There was a median of 2 incisions, with a mean size of 2.30 cm (SD, 1.31). The TME specimens were complete in 101 cases (97.1%) and near complete in 3 cases (2.9%). The R1 rate was 3.8%, with 3 positive distal margins and 1 positive circumferential margin. Postoperatively, there were 15 total complications, of which 4 were major complications and 11 were minor complications. There were 2 readmissions (ileus and small bowel obstruction). There were no mortalities.</div></div><div><h3>Conclusion</h3><div>This early international experience with the SPr procedure showed that it is a safe and effective technique for distal rectal cancers, with excellent specimen quality. The complication and conversion rates observed with other techniques and platforms used in rectal cancer surgery were not demonstrated. An international registry was used to better understand the opportunities and limitations of SPr technology in rectal cancer surgery as the tec
背景:直肠癌手术仍然是一项重大的技术挑战。新技术的开发和应用为更准确、更精确的手术带来了希望。为了评估单孔机器人技术(SPR)是否有助于实现这一目标,我们建立了一个国际SPR机器人注册中心。本研究报告了国际直肠癌 SPR 登记的短期临床和肿瘤学结果:对根据研究设计豁免 (IDE) 批准用于结直肠手术的 SPR 手术的前瞻性国际登记进行了审查。纳入了2018年11月至2022年9月期间使用SPR平台进行根治性切除的直肠腺癌患者。频率统计描述了患者和肿瘤特征以及术中、肿瘤学和临床结果变量。主要结局指标是TME标本的质量。次要结果指标为术中转换、术后30天发病率和死亡率:113例SPR直肠癌病例在2个中心由4名结直肠外科医生进行了手术。排除了 9 例局部切除术,分析了 104 例病例。男性占 50.96%,平均年龄为 60.0 岁(SD 11.29),体重指数为 25.8kg/m2(SD 6.18)。最常见的 T 分期是 3 期(55 人,占 52.8%),其次是 2 期(19 人,占 18.26%)。超过60%的患者在术前接受了新辅助化疗。癌症距离肛门直肠环平均为 2.9 厘米(标清 2.62),大小为 4.52 厘米(标清 1.82)。手术方式包括TATA/TaTME(n=52,46%)、低位前切除(n=49,43.3%)和腹会阴切除(n=3,2.7%)。平均手术时间为 168 分钟(标清 56.9)。术中无并发症,有2例(1.9%)转为腹腔镜手术。手术切口中位数为2个,平均大小为2.3厘米(标准差为1.31)。97.1%(n=101)的TME标本完整,2.9%(n=3)的标本接近完整。R1率为3.8%,其中3例远端和1例周缘阳性。术后共出现15例并发症,其中4例为大并发症,11例为小并发症。2例再次入院(回肠梗阻和小肠梗阻)。无死亡病例:SPR的早期国际经验表明,它是治疗直肠远端癌症的一种安全有效的技术,标本质量极佳。其他用于直肠癌手术的技术和平台的并发症和转归率并未得到证实。随着 SPR 技术在直肠癌手术中得到更广泛的采用和应用,我们希望通过国际注册,更好地了解 SPR 在直肠癌手术中的应用机会和局限性。虽然还需要进行结构化培训和对照试验,以制定最佳实践并确定 SPR 的使用,但初步的国际登记数据还是令人鼓舞的。
{"title":"First clinical report of the international single-port robotic rectal cancer registry","authors":"John H. Marks ,&nbsp;Hye Jin Kim ,&nbsp;Gyu-Seog Choi ,&nbsp;Luis Andres Idrovo ,&nbsp;Suraj Chetty ,&nbsp;Thais Reif De Paula ,&nbsp;Deborah Keller","doi":"10.1016/j.gassur.2024.101929","DOIUrl":"10.1016/j.gassur.2024.101929","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Rectal cancer surgery remains a significant technical challenge. The development and implementation of a new technology offer hope for more accurate and precise surgery. To evaluate whether single-port robotic (SPr) technology helps achieve this goal, an international SPr registry was established. This study reported short-term clinical and oncologic outcomes from an international SPr registry for rectal cancer.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A review of a prospective international registry of SPr technology approved for colorectal surgery with an investigational design exemption was conducted. Patients with rectal adenocarcinoma who had resection for curative intent using the SPr platform between November 2018 and September 2022 were included. Frequency statistics described patient and tumor characteristics and intraoperative, oncologic, and clinical outcome variables. The main outcome measure was the quality of the total mesorectal excision (TME) specimen. The secondary outcome measures were intraoperative conversion and 30-day postoperative morbidity and mortality.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;A total of 113 SPr procedures for rectal cancer were performed at 2 centers by 4 colorectal surgeons. Of note, 9 local excisions were excluded, leaving 104 cases analyzed. The cohort consisted of 53 men (50.96%), had a mean age of 60.00 years (SD, 11.29), and had a body mass index of 25.80 kg/m&lt;sup&gt;2&lt;/sup&gt; (SD, 6.18). The most common T stage was 3 (55 [52.8%]), followed by 2 (19 [18.26%]). More than 60% of patients had preoperative neoadjuvant chemoradiation. The mean tumor distance from the anorectal ring was 2.90 cm (SD, 2.62), and the mean tumor size was 4.52 cm (SD, 1.82). The procedures performed included transanal abdominal transanal/transanal TME (52 [46%]), low anterior resection (49 [43.3%]), and abdominoperineal resection (3 [2.7%]). The mean operating time was 168.0 min (SD, 56.9). There were no intraoperative complications and 2 (1.9%) conversions to laparoscopy. There was a median of 2 incisions, with a mean size of 2.30 cm (SD, 1.31). The TME specimens were complete in 101 cases (97.1%) and near complete in 3 cases (2.9%). The R1 rate was 3.8%, with 3 positive distal margins and 1 positive circumferential margin. Postoperatively, there were 15 total complications, of which 4 were major complications and 11 were minor complications. There were 2 readmissions (ileus and small bowel obstruction). There were no mortalities.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;This early international experience with the SPr procedure showed that it is a safe and effective technique for distal rectal cancers, with excellent specimen quality. The complication and conversion rates observed with other techniques and platforms used in rectal cancer surgery were not demonstrated. An international registry was used to better understand the opportunities and limitations of SPr technology in rectal cancer surgery as the tec","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101929"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The incidence and temporal trend of appendicitis in children: An analysis from the Global Burden of Disease Study 2021 儿童阑尾炎的发病率和时间趋势:2021年全球疾病负担研究分析》。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101935
Ran He , Jianxiong Lai , Ou Jiang , Jian Li

Background

Challenges persist in the management of appendicitis in children, but its incidence and temporal trends have been reported in only a few developed countries. This study aimed to comprehensively investigate the incidence and temporal trends of appendicitis in children at the global, regional, and national levels, providing evidence for implementing and scaling up intervention services to reduce adverse health outcomes.

Methods

This study downloaded incidence data on appendicitis in children from the Global Burden of Disease 2021. Data on number and rate of appendicitis in children were analyzed at the global, sex, age, sociodemographic, regional, and national levels. The percentage changes and average annual percentage changes were calculated. The association between the sociodemographic index (SDI) and incidence of appendicitis in children was also determined by Pearson correlation analysis.

Results

In 2021, the newly diagnosed appendicitis in children was estimated to be 2,193,020, accounting for 12.93% of all cases of appendicitis in the general population. The corresponding incidence rate was estimated to be 109 per 100,000. From 1990 to 2021, the incidence of appendicitis in children increased by 0.3% annually. The incidence varied widely across regions and countries, whereas there was a significant positive association between the incidence rates (R = 0.6620, P <.001) and its percentage changes (R = 0.2234, P =.0013) of appendicitis in children and the SDI.

Conclusion

Appendicitis will continue to be a major public health challenge in children worldwide, especially in transitioning countries and regions. A comprehensive description of the incidence and its changing patterns, increasing awareness, and rational resource allocation are needed to reduce the burden of pediatric appendicitis.
背景:儿童阑尾炎的治疗一直面临挑战,但只有少数发达国家报告了阑尾炎的发病率和时间趋势。本研究旨在从全球、地区和国家层面全面调查儿童阑尾炎的发病率和时间趋势,为实施和扩大干预服务以减少不良健康后果提供证据:本研究从《2021 年全球疾病负担》(GBD)中下载了儿童阑尾炎发病率数据。从全球、性别、年龄、社会地理、地区和国家层面分析了儿童阑尾炎的数量和发病率数据。计算了百分比变化和年均百分比变化。此外,还通过皮尔逊相关分析确定了社会人口指数(SDI)与儿童阑尾炎发病率之间的关系:2021 年,新诊断的儿童阑尾炎病例约为 2193020 例,占总人口阑尾炎病例总数的 12.93%。相应的发病率估计为每 10 万人 109 例。从 1990 年到 2021 年,儿童阑尾炎的发病率每年增加 0.3%。不同地区和国家的发病率差异很大,但发病率之间存在显著的正相关关系(R=0.6620,P 结论:阑尾炎将继续成为儿童健康的杀手:阑尾炎仍将是全球儿童公共卫生的一大挑战,尤其是在转型国家和地区。要减轻小儿阑尾炎的负担,就必须全面描述其发病率及其变化规律,提高人们的认识,并合理分配资源。
{"title":"The incidence and temporal trend of appendicitis in children: An analysis from the Global Burden of Disease Study 2021","authors":"Ran He ,&nbsp;Jianxiong Lai ,&nbsp;Ou Jiang ,&nbsp;Jian Li","doi":"10.1016/j.gassur.2024.101935","DOIUrl":"10.1016/j.gassur.2024.101935","url":null,"abstract":"<div><h3>Background</h3><div>Challenges persist in the management of appendicitis in children, but its incidence and temporal trends have been reported in only a few developed countries. This study aimed to comprehensively investigate the incidence and temporal trends of appendicitis in children at the global, regional, and national levels, providing evidence for implementing and scaling up intervention services to reduce adverse health outcomes.</div></div><div><h3>Methods</h3><div>This study downloaded incidence data on appendicitis in children from the Global Burden of Disease 2021. Data on number and rate of appendicitis in children were analyzed at the global, sex, age, sociodemographic, regional, and national levels. The percentage changes and average annual percentage changes were calculated. The association between the sociodemographic index (SDI) and incidence of appendicitis in children was also determined by Pearson correlation analysis.</div></div><div><h3>Results</h3><div>In 2021, the newly diagnosed appendicitis in children was estimated to be 2,193,020, accounting for 12.93% of all cases of appendicitis in the general population. The corresponding incidence rate was estimated to be 109 per 100,000. From 1990 to 2021, the incidence of appendicitis in children increased by 0.3% annually. The incidence varied widely across regions and countries, whereas there was a significant positive association between the incidence rates (R = 0.6620, <em>P</em> &lt;.001) and its percentage changes (R = 0.2234, <em>P</em> =.0013) of appendicitis in children and the SDI.</div></div><div><h3>Conclusion</h3><div>Appendicitis will continue to be a major public health challenge in children worldwide, especially in transitioning countries and regions. A comprehensive description of the incidence and its changing patterns, increasing awareness, and rational resource allocation are needed to reduce the burden of pediatric appendicitis.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101935"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142864557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is end-to-end or side-to-end anastomotic configuration associated with risk of positive intraoperative air leak test in left-sided colon and rectal resections for colon and rectal cancers? 端到端或端到端吻合器配置是否与左结肠和直肠癌切除术中漏气试验阳性的风险相关?
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101899
Sami Alahmadi , David L. Berger , Christy E. Cauley , Robert N. Goldstone , William V. Kastrinakis , Marc Rubin , Hiroko Kunitake , Rocco Ricciardi , Grace C. Lee

Background

Anastomotic leak after colorectal resection is associated with morbidity, mortality, and poor bowel function. Minimal data exist on the relationship between anastomotic technique, intraoperative leak test, and subsequent clinical leak, particularly on the utility of performing end-to-end anastomosis (EEA) vs non–EEA (NEEA) to avoid postoperative leaks. This study aimed to analyze potential associations between anastomotic construction, intraoperative anastomotic assessments, and clinical leak.

Methods

This was a retrospective cohort study comparing anastomotic techniques used in patients with colorectal cancer who underwent left-sided colorectal resections with colorectal or coloanal anastomoses at a tertiary care center. The outcomes were rates of intraoperative air leak, incomplete anastomotic donuts, and postoperative clinical leak. Univariate and multivariate analyses were performed to evaluate the potential association between anastomotic technique and intraoperative anastomotic assessments and subsequent leak.

Results

Among 844 patients, 27 (3.2%) had intraoperative leak, 6 (0.7%) had incomplete donuts, and 27 (3.2%) experienced clinical leak. Of note, 500 patients (59.2%) had EEAs, and 344 patients (40.7%) had NEEAs. There were no significant differences in demographics or comorbidities between groups (P >.05) or rates of incomplete donuts (P =.07). EEA was associated with significantly more intraoperative air leaks than NEEA on univariate analysis (4.9% vs 1.2%, respectively; P =.005) and multivariate analysis (odds ratio [OR], 3.6; 95% CI, 1.01–12.50; P =.049). There was no difference in postoperative clinical leak between the groups on univariate analysis (3.0% in EEA vs 3.5% in NEEA; P =.69) or multivariate analysis (OR, 0.97; 95% CI, 0.40–2.34; P =.94).

Conclusion

EEA is associated with higher rates of intraoperative air leak than NEEA, even after adjusting for potential confounders.
背景:结直肠切除术后吻合口漏与发病率、死亡率和肠功能不良有关。关于吻合技术、术中泄漏试验和随后的临床泄漏之间关系的数据很少,特别是关于端到端与非端到端吻合以避免术后泄漏的效用。本研究的目的是分析吻合口构造、术中吻合口评估和临床泄漏之间的潜在关联。方法:我们对某三级保健中心的结肠直肠癌患者进行了一项回顾性队列研究,这些患者接受了左侧结肠直肠切除术并进行了结肠直肠或结肠直肠吻合术,比较了吻合技术。结果为术中漏气率、吻合口不完整甜甜圈率和术后临床漏气率。进行单因素和多因素分析以评估吻合技术与术中吻合口评估和随后的吻合口泄漏之间的潜在关联。结果/结局:844例患者中,27例(3.2%)患者术中漏气,6例(0.7%)患者甜甜圈不完整,27例(3.2%)患者临床漏气。端到端吻合500例(59.2%),非端到端吻合344例(40.7%)。两组在人口统计学、合并症和不完整甜甜圈率方面均无显著差异(p < 0.05)。单因素分析(4.9% vs 1.2%, p=0.005)和多因素分析(OR 3.6;95% CI 1.01-12.5, p= 0.049)。单因素分析(3.0% vs 3.5%, p=0.69)和多因素分析(or: 0.97;95% ci: 0.40-2.34;p = 0.94)。结论:端到端吻合术中漏气率高于非端到端吻合术,即使在调整潜在混杂因素后也是如此。
{"title":"Is end-to-end or side-to-end anastomotic configuration associated with risk of positive intraoperative air leak test in left-sided colon and rectal resections for colon and rectal cancers?","authors":"Sami Alahmadi ,&nbsp;David L. Berger ,&nbsp;Christy E. Cauley ,&nbsp;Robert N. Goldstone ,&nbsp;William V. Kastrinakis ,&nbsp;Marc Rubin ,&nbsp;Hiroko Kunitake ,&nbsp;Rocco Ricciardi ,&nbsp;Grace C. Lee","doi":"10.1016/j.gassur.2024.101899","DOIUrl":"10.1016/j.gassur.2024.101899","url":null,"abstract":"<div><h3>Background</h3><div>Anastomotic leak after colorectal resection is associated with morbidity, mortality, and poor bowel function. Minimal data exist on the relationship between anastomotic technique, intraoperative leak test, and subsequent clinical leak, particularly on the utility of performing end-to-end anastomosis (EEA) vs non–EEA (NEEA) to avoid postoperative leaks. This study aimed to analyze potential associations between anastomotic construction, intraoperative anastomotic assessments, and clinical leak.</div></div><div><h3>Methods</h3><div>This was a retrospective cohort study comparing anastomotic techniques used in patients with colorectal cancer who underwent left-sided colorectal resections with colorectal or coloanal anastomoses at a tertiary care center. The outcomes were rates of intraoperative air leak, incomplete anastomotic donuts, and postoperative clinical leak. Univariate and multivariate analyses were performed to evaluate the potential association between anastomotic technique and intraoperative anastomotic assessments and subsequent leak.</div></div><div><h3>Results</h3><div>Among 844 patients, 27 (3.2%) had intraoperative leak, 6 (0.7%) had incomplete donuts, and 27 (3.2%) experienced clinical leak. Of note, 500 patients (59.2%) had EEAs, and 344 patients (40.7%) had NEEAs. There were no significant differences in demographics or comorbidities between groups (<em>P</em> &gt;.05) or rates of incomplete donuts (<em>P</em> =.07). EEA was associated with significantly more intraoperative air leaks than NEEA on univariate analysis (4.9% vs 1.2%, respectively; <em>P</em> =.005) and multivariate analysis (odds ratio [OR], 3.6; 95% CI, 1.01–12.50; <em>P</em> =.049). There was no difference in postoperative clinical leak between the groups on univariate analysis (3.0% in EEA vs 3.5% in NEEA; <em>P</em> =.69) or multivariate analysis (OR, 0.97; 95% CI, 0.40–2.34; <em>P</em> =.94).</div></div><div><h3>Conclusion</h3><div>EEA is associated with higher rates of intraoperative air leak than NEEA, even after adjusting for potential confounders.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101899"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An isolated pancreatic myeloid sarcoma 一例孤立的胰腺髓系肉瘤。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101923
Long He , Hongzhen Wei , Tao Yin
{"title":"An isolated pancreatic myeloid sarcoma","authors":"Long He ,&nbsp;Hongzhen Wei ,&nbsp;Tao Yin","doi":"10.1016/j.gassur.2024.101923","DOIUrl":"10.1016/j.gassur.2024.101923","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101923"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy evaluation of postoperative adjuvant TACE in preventing HCC recurrence within Milan criteria: A multi-center propensity score matching analysis based on pathological indicators.
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2025.101978
Kun He, Yongqiang Xiao, Shuju Tu, Yourao Li, Zhao Wu, Liping Liu, Wei Shen, Shiyun Bao, Yongzhu He

Objective: Malignant biological behaviors such as microvascular invasion (MVI), satellite nodule formation and poor differentiation can appear in the postoperative pathology of early hepatocellular carcinoma (HCC), which often indicates that it has entered the stage of malignant evolution earlier. This study aimed to evaluate tumor recurrence in HCC patients meeting the Milan criteria who underwent postoperative adjuvant transarterial chemoembolization (PA-TACE) based on postoperative pathological indices.

Methods: A retrospective study was conducted on 790 HCC patients within the Milan criteria who underwent hepatectomy across four medical centers, comprising 366 patients treated with PA-TACE and 424 patients without PA-TACE. To reduce selection bias, propensity score matching (PSM) at a 1:1 ratio was applied, achieving balanced clinical characteristics between the two groups.

Results: Patients receiving PA-TACE did not experience more severe adverse events or toxicity-related deaths. After PSM of each subgroup, it was found that patients with MVI (Median time: 37 months vs 17 months, p = 0.010), satellite nodules (Median time: NA vs 14 months, p = 0.018), and Edmondson-Steiner grade III-IV (Median time: NA vs 13 months, p = 0.004) who received PA-TACE had higher recurrence-free survival (RFS). However, patients who were MVI-negative, satellite nodule-negative, and Edmondson-Steiner grade I-II did not benefit from PA-TACE in terms of RFS (All p > 0.05). Patients who received PA-TACE were more likely to undergo liver transplantation, re-hepatectomy, and local ablation after tumor recurrence, whereas patients who did not receive PA-TACE were more likely to receive TACE, chemoradiotherapy, and immunotargeted therapy after tumor recurrence (All p < 0.05).

Conclusion: Postoperative pathological indicators can guide the selection of PA-TACE for patients with HCC within the Milan criteria. Patients with MVI, satellite nodules, and Edmondson-Steiner grade III-IV are more suitable for receiving PA-TACE to improve RFS. PA-TACE may alter the recurrence pattern of tumors, rendering them more localized.

{"title":"Efficacy evaluation of postoperative adjuvant TACE in preventing HCC recurrence within Milan criteria: A multi-center propensity score matching analysis based on pathological indicators.","authors":"Kun He, Yongqiang Xiao, Shuju Tu, Yourao Li, Zhao Wu, Liping Liu, Wei Shen, Shiyun Bao, Yongzhu He","doi":"10.1016/j.gassur.2025.101978","DOIUrl":"https://doi.org/10.1016/j.gassur.2025.101978","url":null,"abstract":"<p><strong>Objective: </strong>Malignant biological behaviors such as microvascular invasion (MVI), satellite nodule formation and poor differentiation can appear in the postoperative pathology of early hepatocellular carcinoma (HCC), which often indicates that it has entered the stage of malignant evolution earlier. This study aimed to evaluate tumor recurrence in HCC patients meeting the Milan criteria who underwent postoperative adjuvant transarterial chemoembolization (PA-TACE) based on postoperative pathological indices.</p><p><strong>Methods: </strong>A retrospective study was conducted on 790 HCC patients within the Milan criteria who underwent hepatectomy across four medical centers, comprising 366 patients treated with PA-TACE and 424 patients without PA-TACE. To reduce selection bias, propensity score matching (PSM) at a 1:1 ratio was applied, achieving balanced clinical characteristics between the two groups.</p><p><strong>Results: </strong>Patients receiving PA-TACE did not experience more severe adverse events or toxicity-related deaths. After PSM of each subgroup, it was found that patients with MVI (Median time: 37 months vs 17 months, p = 0.010), satellite nodules (Median time: NA vs 14 months, p = 0.018), and Edmondson-Steiner grade III-IV (Median time: NA vs 13 months, p = 0.004) who received PA-TACE had higher recurrence-free survival (RFS). However, patients who were MVI-negative, satellite nodule-negative, and Edmondson-Steiner grade I-II did not benefit from PA-TACE in terms of RFS (All p > 0.05). Patients who received PA-TACE were more likely to undergo liver transplantation, re-hepatectomy, and local ablation after tumor recurrence, whereas patients who did not receive PA-TACE were more likely to receive TACE, chemoradiotherapy, and immunotargeted therapy after tumor recurrence (All p < 0.05).</p><p><strong>Conclusion: </strong>Postoperative pathological indicators can guide the selection of PA-TACE for patients with HCC within the Milan criteria. Patients with MVI, satellite nodules, and Edmondson-Steiner grade III-IV are more suitable for receiving PA-TACE to improve RFS. PA-TACE may alter the recurrence pattern of tumors, rendering them more localized.</p>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":" ","pages":"101978"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoluminal approaches for colorectal neoplasia in inflammatory bowel disease: a viable alternative for colectomy? 炎症性肠病结肠直肠肿瘤的腔内治疗方法,结肠切除术的可行替代方案?
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101876
Ali Alipouriani, Stefan D. Holubar, Kamil Erozkan, Lukas Schabl, Joshua Sommovilla, Michael Valente, Scott R. Steele, Emre Gorgun

Background

Endoscopic resection of visible dysplastic lesions in patients with inflammatory bowel disease (IBD) is an alternative to colectomy. The endoscopic techniques that can be used include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and ESD combined with EMR. These endoscopic approaches may allow organ preservation in patients with IBD. This study aimed to evaluate the outcomes of endoscopic resection, including EMR, ESD, and ESD combined with EMR, for the treatment of colorectal dysplasia in patients with IBD.

Methods

This was a retrospective review of patients with IBD who underwent endoscopic resection for colorectal dysplasia at our tertiary care center between 2014 and 2023. Patients were identified via a search of our endoscopy database. Medical records were reviewed to collect data on patient demographics, IBD history, details of endoscopic technique, procedural factors, final pathology results, and outcomes, including recurrence of dysplasia.

Results

A total of 50 patients with IBD who underwent endoscopic resection were included in the study, with 38 ESD cases, 11 ESD combined with EMR cases, and 1 EMR case. The median age was 62 years, (IQR, 54–68), and 34 patients (68%) were male. The median body mass index was 27.6 kg/m2 (IQR, 24.8–31.7). The underlying diagnoses were ulcerative colitis in 33 patients (66%) and Crohn’s disease in 17 patients (33%). The median disease duration was 27.5 years (IQR, 8–30). Polyp locations were distributed as follows: right colon, rectum, left colon, transverse colon, and cecum, with 9 polyps (18%) in each area. The median procedure time was 47.5 min (IQR, 31.2–73.7). En bloc resection was performed in 34 patients (68%), and piecemeal resection was performed in 16 patients (32%). On pathology, the median lesion size was 23.5 mm (IQR, 20.2–40.0). High-grade dysplasia was found in 7 patients (14%), whereas low-grade dysplasia was found in 15 patients (30%). During a median follow-up period of 3 years, 18% of patients experienced recurrence. No significant difference in recurrence rates was observed between the ESD and ESD combined with EMR groups.

Conclusion

Endoscopic resection, including EMR, ESD, and ESD combined with EMR, is an effective treatment of visible dysplastic lesions and is a safe alternative to colectomy in patients with IBD. In this cohort, favorable short-term outcomes were observed after endoscopic resection.
导言:内镜下切除炎症性肠病(IBD)患者可见的发育不良病灶是结肠切除术以外的另一种治疗方法。可采用的内镜技术包括内镜下粘膜切除术(EMR)、内镜下粘膜下剥离术(ESD)以及ESD和EMR的混合方法。这些内镜治疗方法可以保留 IBD 患者的器官。本研究旨在评估内镜下切除术(包括EMR、ESD和ESD/EMR混合术)治疗IBD患者结直肠发育不良的效果:我们对2014年至2023年期间在我们的三级医疗中心接受内镜切除术治疗结直肠发育不良的IBD患者进行了回顾性研究。我们通过搜索内镜数据库确定了患者。对病历进行审查,以收集有关患者人口统计学、IBD病史、内镜技术细节、手术因素、最终病理结果以及包括发育不良复发在内的结果的数据:共有50名IBD患者接受了内镜切除术,包括38例ESD、11例ESD/EMR混合术和1例EMR。中位年龄为 62 岁(IQR:54-68),男性 34 人(68%)。体重指数中位数为 27.6(IQR:24.8-31.7)。33人(66%)被诊断为溃疡性结肠炎,17人(33%)被诊断为克罗恩病。中位病程为 27.5 年(IQR:8-30)。息肉位置分布如下:右结肠、直肠、左结肠、横结肠和盲肠,每个部位有 9 个(18%)。手术时间中位数为 47.5 分钟(IQR:31.2-73.7)。34例(68%)实现了整块切除,16例(32%)实现了分块切除。病理结果显示,中位病灶大小为 23.5 毫米(IQR:20.2-40)。7例(14%)发现高级别发育不良,15例(30%)发现低级别发育不良。在中位 7.2 年的随访期间,18% 的患者复发。ESD组和ESD/EMR组的复发率无明显差异:结论:内镜下切除术,包括EMR、ESD和混合技术,可以有效治疗可见的发育不良病变,作为IBD患者结肠切除术的替代方案。在这组患者中,内镜切除术后的短期疗效良好。
{"title":"Endoluminal approaches for colorectal neoplasia in inflammatory bowel disease: a viable alternative for colectomy?","authors":"Ali Alipouriani,&nbsp;Stefan D. Holubar,&nbsp;Kamil Erozkan,&nbsp;Lukas Schabl,&nbsp;Joshua Sommovilla,&nbsp;Michael Valente,&nbsp;Scott R. Steele,&nbsp;Emre Gorgun","doi":"10.1016/j.gassur.2024.101876","DOIUrl":"10.1016/j.gassur.2024.101876","url":null,"abstract":"<div><h3>Background</h3><div>Endoscopic resection of visible dysplastic lesions in patients with inflammatory bowel disease (IBD) is an alternative to colectomy. The endoscopic techniques that can be used include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and ESD combined with EMR. These endoscopic approaches may allow organ preservation in patients with IBD. This study aimed to evaluate the outcomes of endoscopic resection, including EMR, ESD, and ESD combined with EMR, for the treatment of colorectal dysplasia in patients with IBD.</div></div><div><h3>Methods</h3><div>This was a retrospective review of patients with IBD who underwent endoscopic resection for colorectal dysplasia at our tertiary care center between 2014 and 2023. Patients were identified via a search of our endoscopy database. Medical records were reviewed to collect data on patient demographics, IBD history, details of endoscopic technique, procedural factors, final pathology results, and outcomes, including recurrence of dysplasia.</div></div><div><h3>Results</h3><div>A total of 50 patients with IBD who underwent endoscopic resection were included in the study, with 38 ESD cases, 11 ESD combined with EMR cases, and 1 EMR case. The median age was 62 years, (IQR, 54–68), and 34 patients (68%) were male. The median body mass index was 27.6 kg/m<sup>2</sup> (IQR, 24.8–31.7). The underlying diagnoses were ulcerative colitis in 33 patients (66%) and Crohn’s disease in 17 patients (33%). The median disease duration was 27.5 years (IQR, 8–30). Polyp locations were distributed as follows: right colon, rectum, left colon, transverse colon, and cecum, with 9 polyps (18%) in each area. The median procedure time was 47.5 min (IQR, 31.2–73.7). En bloc resection was performed in 34 patients (68%), and piecemeal resection was performed in 16 patients (32%). On pathology, the median lesion size was 23.5 mm (IQR, 20.2–40.0). High-grade dysplasia was found in 7 patients (14%), whereas low-grade dysplasia was found in 15 patients (30%). During a median follow-up period of 3 years, 18% of patients experienced recurrence. No significant difference in recurrence rates was observed between the ESD and ESD combined with EMR groups.</div></div><div><h3>Conclusion</h3><div>Endoscopic resection, including EMR, ESD, and ESD combined with EMR, is an effective treatment of visible dysplastic lesions and is a safe alternative to colectomy in patients with IBD. In this cohort, favorable short-term outcomes were observed after endoscopic resection.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101876"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142621983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of gut microbiota and metabolites on pancreatitis: a 2-sample Mendelian randomization study 肠道微生物群和代谢物对胰腺炎的影响:双样本孟德尔随机研究
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101885
Zhirong Zhao , Li Han , Baobaonai Tuerxunbieke , Lan Ming , Jiamin Ji , Yuan Chen , Ran Sun , Weiliang Tian , Fan Yang , Qian Huang

Background

Acute pancreatitis (AP) and chronic pancreatitis (CP) have high incidences and poor prognoses. The early screening of at-risk populations still awaits further study. The limitation was mainly based on observational studies, with limited sample size and the presence of confounding factors. This study used a 2-sample Mendelian randomization (MR) analysis based on publicly available data from genome-wide association studies to reveal the causal effect of gut microbiota and metabolites on pancreatitis.

Methods

This study collected summary statistics on gut microbiota, metabolites, AP, and CP. A 2-sample MR analysis was performed using MR-Egger, inverse variance-weighted, MR Pleiotropy RESidual Sum and Outlier, maximum likelihood, and weighted median.

Results

The 2-sample MR showed that only Eubacterium coprostanoligenes was an independent protective factor for AP among all gut microbiota, and the other microbiota were not significant for pancreatitis. Unsaturated fatty acids in metabolites are protective factors for both AP (odds ratio [OR], 0.730; 95% CI, 0.593–0.899; P = .003) and CP (OR, 0.660; 95% CI, 0.457–0.916; P = .013). Furthermore, carnitine was a protective factor CP, and glucose was an independent risk factor for CP.

Conclusion

This study provides potential evidence of the causal role of gut microbiota and metabolites on pancreatitis, which may be conducive for designing microbiome and metabolite interventions on AP or CP in the future.
背景:急性和慢性胰腺炎(AP 和 CP)发病率高、预后差。高危人群的早期筛查仍有待进一步研究。目前的研究主要基于观察性研究,样本量有限且存在混杂因素。我们根据全基因组关联研究(GWAS)的公开数据,采用双样本 MR 分析,揭示肠道微生物群和代谢物对胰腺炎的因果影响:本研究收集了有关肠道微生物群、代谢物、AP 和 CP 的简要统计数据。采用 MR-Egger、逆方差加权(IVW)、MR-PRESSO、最大似然法和加权中位数进行了双样本孟德尔随机分析:结果:双样本孟德尔随机分析表明,在所有肠道微生物群中,只有Eubacterium coprostanoligenes是胰腺炎的独立保护因子,其他微生物群对胰腺炎的影响并不显著。代谢物中的不饱和脂肪酸是胰腺炎(OR=0.730,95% Cl:0.593-0.899,P = 0.003)和胰腺癌(OR=0.660,95% Cl:0.457-0.916,P = 0.013)的保护因素。此外,肉碱是CP的保护因素,但葡萄糖是CP的独立风险因素:本研究首次提供了肠道微生物群和代谢物对胰腺炎的因果作用的潜在证据,这可能有利于在未来的深入研究中设计微生物群和代谢物对 AP 或 CP 的干预措施。
{"title":"Effects of gut microbiota and metabolites on pancreatitis: a 2-sample Mendelian randomization study","authors":"Zhirong Zhao ,&nbsp;Li Han ,&nbsp;Baobaonai Tuerxunbieke ,&nbsp;Lan Ming ,&nbsp;Jiamin Ji ,&nbsp;Yuan Chen ,&nbsp;Ran Sun ,&nbsp;Weiliang Tian ,&nbsp;Fan Yang ,&nbsp;Qian Huang","doi":"10.1016/j.gassur.2024.101885","DOIUrl":"10.1016/j.gassur.2024.101885","url":null,"abstract":"<div><h3>Background</h3><div>Acute pancreatitis (AP) and chronic pancreatitis (CP) have high incidences and poor prognoses. The early screening of at-risk populations still awaits further study. The limitation was mainly based on observational studies, with limited sample size and the presence of confounding factors. This study used a 2-sample Mendelian randomization (MR) analysis based on publicly available data from genome-wide association studies to reveal the causal effect of gut microbiota and metabolites on pancreatitis.</div></div><div><h3>Methods</h3><div>This study collected summary statistics on gut microbiota, metabolites, AP, and CP. A 2-sample MR analysis was performed using MR-Egger, inverse variance-weighted, MR Pleiotropy RESidual Sum and Outlier, maximum likelihood, and weighted median.</div></div><div><h3>Results</h3><div>The 2-sample MR showed that only <em>Eubacterium coprostanoligenes</em> was an independent protective factor for AP among all gut microbiota, and the other microbiota were not significant for pancreatitis. Unsaturated fatty acids in metabolites are protective factors for both AP (odds ratio [OR], 0.730; 95% CI, 0.593–0.899; <em>P</em> = .003) and CP (OR, 0.660; 95% CI, 0.457–0.916; <em>P</em> = .013). Furthermore, carnitine was a protective factor CP, and glucose was an independent risk factor for CP.</div></div><div><h3>Conclusion</h3><div>This study provides potential evidence of the causal role of gut microbiota and metabolites on pancreatitis, which may be conducive for designing microbiome and metabolite interventions on AP or CP in the future.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101885"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term follow-up of sacrococcygeal pilonidal sinus disease after previous abscess drainage: a retrospective cohort study 脓肿引流术后骶尾部乳头窦疾病的长期随访;一项回顾性队列研究。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101892
Jochem de Kort , Anne Akke Pronk , Menno R. Vriens , Niels Smakman , Edgar J.B. Furnee
{"title":"Long-term follow-up of sacrococcygeal pilonidal sinus disease after previous abscess drainage: a retrospective cohort study","authors":"Jochem de Kort ,&nbsp;Anne Akke Pronk ,&nbsp;Menno R. Vriens ,&nbsp;Niels Smakman ,&nbsp;Edgar J.B. Furnee","doi":"10.1016/j.gassur.2024.101892","DOIUrl":"10.1016/j.gassur.2024.101892","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101892"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142687262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative skeletal muscle loss as a prognostic indicator of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis 术后骨骼肌损失作为胃癌患者临床预后的预后指标:一项系统综述和荟萃分析
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101898
Chenyang Zhan , Jun Bu , Sheng Li , Xiujin Huang , Zongjie Quan

Background

A decrease in skeletal muscle mass is frequently observed during the perioperative period in patients with gastric cancer (GC) and is strongly associated with postoperative complications and poor long-term survival outcomes. Relevant research indicates that a certain proportion of patients with GC experience skeletal muscle mass loss after surgery. Therefore, a systematic review and meta-analysis was conducted to assess postoperative skeletal muscle loss as a prognostic marker for clinical outcomes in patients with GC.

Methods

PubMed, Web of Science, and Embase were used to systematically screen and retrieve relevant studies according to strictly established inclusion and exclusion criteria. Further analysis of the effect of postoperative skeletal muscle loss on long-term survival metrics (including overall survival [OS], recurrence-free survival [RFS], disease-free survival [DFS], and disease-specific survival [DSS]) in patients with GC was performed.

Results’

From 10 studies and 11 related publications, more than 3764 patients with GC were identified. Severe postoperative skeletal muscle loss occurred in 25.7% of patients with GC and was significantly correlated with poorer OS (hazard ratio [HR], 2.27; 95% CI, 1.58–3.25; P <.00001), RFS (HR, 2.96; 95% CI, 1.47–5.97; P =.002), DFS (HR, 2.41; 95% CI, 1.17–4.97; P =.02), and DSS (HR, 4.12; 95% CI, 2.44–6.94; P <.00001). When postoperative skeletal muscle loss advanced to sarcopenia, patients had worse OS as well (HR, 2.22; 95% CI, 1.49–3.30; P <.0001).

Conclusion

Patients who undergo radical surgery for GC often experience skeletal muscle mass loss, and significant skeletal muscle mass loss is associated with poorer survival outcomes. Identifying patients with significant skeletal muscle mass loss during follow-up and promptly providing tailored interventions, such as nutritional and exercise support, are essential.
目的:在胃癌(GC)患者围手术期经常观察到骨骼肌质量的减少,并与术后并发症和不良的长期生存结果密切相关。相关研究表明,有一定比例的胃癌患者术后出现骨骼肌质量下降。因此,我们进行了一项系统回顾和荟萃分析,以评估术后骨骼肌损失作为胃癌患者临床结局的预后指标。方法:采用PubMed、Web of Science和Embase数据库,按照严格制定的纳入和排除标准,系统筛选和检索相关研究。我们进一步分析了术后骨骼肌损失对胃癌患者长期生存指标(包括总生存期(OS)、无复发生存期(RFS)、无病生存期(DFS)、疾病特异性生存期(DSS))的影响。结果:从10项研究和11篇相关出版物中,确定了超过3764例GC患者。25.7%的GC患者发生严重的术后骨骼肌损失,并与较差的OS (HR=2.27, 95%CI, 1.58-3.25, p < 0.00001)、RFS (HR=2.96, 95%CI, 1.47-5.97, p=0.002)、DFS (HR=2.41, 95%CI, 1.17-4.97, p=0.02)、DSS (HR=4.12, 95%CI, 2.44-6.94, p < 0.00001)显著相关。当术后骨骼肌损失进展为肌肉减少时,患者的OS也更差(HR=2.22, 95%CI, 1.49 ~ 3.30, p < 0.0001)。结论:接受胃癌根治性手术的患者经常出现骨骼肌质量下降,而骨骼肌质量明显下降与较差的生存结果有关。在随访期间确定骨骼肌质量明显下降的患者,并及时提供量身定制的干预措施,如营养和运动支持,是至关重要的。
{"title":"Postoperative skeletal muscle loss as a prognostic indicator of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis","authors":"Chenyang Zhan ,&nbsp;Jun Bu ,&nbsp;Sheng Li ,&nbsp;Xiujin Huang ,&nbsp;Zongjie Quan","doi":"10.1016/j.gassur.2024.101898","DOIUrl":"10.1016/j.gassur.2024.101898","url":null,"abstract":"<div><h3>Background</h3><div>A decrease in skeletal muscle mass is frequently observed during the perioperative period in patients with gastric cancer (GC) and is strongly associated with postoperative complications and poor long-term survival outcomes. Relevant research indicates that a certain proportion of patients with GC experience skeletal muscle mass loss after surgery. Therefore, a systematic review and meta-analysis was conducted to assess postoperative skeletal muscle loss as a prognostic marker for clinical outcomes in patients with GC.</div></div><div><h3>Methods</h3><div>PubMed, Web of Science, and Embase were used to systematically screen and retrieve relevant studies according to strictly established inclusion and exclusion criteria. Further analysis of the effect of postoperative skeletal muscle loss on long-term survival metrics (including overall survival [OS], recurrence-free survival [RFS], disease-free survival [DFS], and disease-specific survival [DSS]) in patients with GC was performed.</div></div><div><h3>Results’</h3><div>From 10 studies and 11 related publications, more than 3764 patients with GC were identified. Severe postoperative skeletal muscle loss occurred in 25.7% of patients with GC and was significantly correlated with poorer OS (hazard ratio [HR], 2.27; 95% CI, 1.58–3.25; <em>P</em> &lt;.00001), RFS (HR, 2.96; 95% CI, 1.47–5.97; <em>P</em> =.002), DFS (HR, 2.41; 95% CI, 1.17–4.97; <em>P</em> =.02), and DSS (HR, 4.12; 95% CI, 2.44–6.94; <em>P</em> &lt;.00001). When postoperative skeletal muscle loss advanced to sarcopenia, patients had worse OS as well (HR, 2.22; 95% CI, 1.49–3.30; <em>P</em> &lt;.0001).</div></div><div><h3>Conclusion</h3><div>Patients who undergo radical surgery for GC often experience skeletal muscle mass loss, and significant skeletal muscle mass loss is associated with poorer survival outcomes. Identifying patients with significant skeletal muscle mass loss during follow-up and promptly providing tailored interventions, such as nutritional and exercise support, are essential.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101898"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma 肝细胞癌手术时间与肿瘤负荷评分的相互作用分析。
IF 2.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.gassur.2024.101903
Miho Akabane , Jun Kawashima , Selamawit Woldesenbet , Abdullah Altaf , François Cauchy , Federico Aucejo , Irinel Popescu , Minoru Kitago , Guillaume Martel , Francesca Ratti , Luca Aldrighetti , George A. Poultsides , Yuki Imaoka , Andrea Ruzzenente , Itaru Endo , Ana Gleisner , Hugo P. Marques , Vincent Lam , Tom Hugh , Nazim Bhimani , Timothy M. Pawlik

Background

The effect of “time to surgery (TTS)” on outcomes for curative-intent hepatectomy of hepatocellular carcinoma (HCC) remains debated. The interaction between tumor burden score (TBS) and TTS remains unclear. We sought to evaluate the effects of TBS and TTS on long-term HCC outcomes.

Methods

Patients with HCC who underwent curative-intent hepatectomy (2000–2022) were analyzed from a multi-institutional database and categorized by TTS (≤60 or >60 days). Overall survival (OS) and cancer-specific survival were assessed.

Results

Among 910 patients, median TTS estimates were 22 days in the short TTS group (n = 485) and 120 days in the long TTS group (n = 425). Patients with long TTS were older and were more likely to have American Society of Anesthesiologists class >2, diabetes mellitus, and cirrhosis. There was no difference in median TBS among patients who had short versus long TTS (4.61 vs 5.00, respectively). In addition, there was no difference in 5-year OS (70.0% vs 63.1%, respectively; P =.05). On multivariate analysis TBS (hazard ratio [HR], 1.07; 95% CI, 1.03–1.11; P <.001), log alpha-fetoprotein (HR, 1.08; 95% CI, 1.01–1.14; P =.02), and albumin-bilirubin score (HR, 2.52; 95% CI, 1.66–3.82; P <.001) were associated with OS. In contrast, TTS was not associated with OS (HR, 1.18; 95% CI, 0.78–1.77; P =.43). Interaction analysis demonstrated that TBS was asssociated with OS among patients with short TTS (HR, 1.12; 95% CI, 1.07–1.17; P <.001), but not among patients with long TTS (HR, 0.98; 95% CI, 0.91–1.05; P =.56). Among patients with low TBS (≤5), higher mortality was observed with long TTS versus short TTS (5-year OS: 82.4% vs 63.0%, respectively; P =.001); however, TTS was not associated with OS among patients with high TBS (5-year OS: 57.9% vs 63.3%, respectively; P =.92). Multivariate analysis demonstrated that long TTS was a risk factor for OS among patients with low TBS (HR, 3.12; 95% CI, 1.60–6.01; P <.001), but not among individuals with high TBS (HR, 0.57; 95% CI, 0.30–1.07; P =.08). Similar trends were observed relative to cancer-specific survival.

Conclusion

TTS needs to be considered in light of patient and tumor-specific factors. Expediting TTS may be particularly important among patients with HCC and a low TBS.
背景:“手术时间(TTS)”对肝细胞癌(HCC)治疗目的肝切除术结果的影响存在争议。肿瘤负荷评分(Tumor Burden Score, TBS)与TTS之间的相互作用尚不清楚。本研究评估TBS和TTS如何影响HCC的长期预后。方法:从多机构数据库中分析2000-2022年接受治愈性肝切除术的HCC患者,并按TTS(≤或≤60天)进行分类。评估总生存期(OS)和癌症特异性生存期。结果:910例患者中,短TTS组(n=485)中位TTS为22天,长TTS组(n=425)中位TTS为120天。长期TTS组年龄较大,ASA >2级、糖尿病和肝硬化的发生率较高。中位TBS组间差异无统计学意义(4.61vs5.00)。5年OS差异无统计学意义(70.0%vs63.1%, P=0.05)。多变量分析确定TBS (HR:1.07[1.03-1.11])。结论:术前优化是必要的,减少TTS可能改善低TBS队列的预后。
{"title":"Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma","authors":"Miho Akabane ,&nbsp;Jun Kawashima ,&nbsp;Selamawit Woldesenbet ,&nbsp;Abdullah Altaf ,&nbsp;François Cauchy ,&nbsp;Federico Aucejo ,&nbsp;Irinel Popescu ,&nbsp;Minoru Kitago ,&nbsp;Guillaume Martel ,&nbsp;Francesca Ratti ,&nbsp;Luca Aldrighetti ,&nbsp;George A. Poultsides ,&nbsp;Yuki Imaoka ,&nbsp;Andrea Ruzzenente ,&nbsp;Itaru Endo ,&nbsp;Ana Gleisner ,&nbsp;Hugo P. Marques ,&nbsp;Vincent Lam ,&nbsp;Tom Hugh ,&nbsp;Nazim Bhimani ,&nbsp;Timothy M. Pawlik","doi":"10.1016/j.gassur.2024.101903","DOIUrl":"10.1016/j.gassur.2024.101903","url":null,"abstract":"<div><h3>Background</h3><div>The effect of “time to surgery (TTS)” on outcomes for curative-intent hepatectomy of hepatocellular carcinoma (HCC) remains debated. The interaction between tumor burden score (TBS) and TTS remains unclear. We sought to evaluate the effects of TBS and TTS on long-term HCC outcomes.</div></div><div><h3>Methods</h3><div>Patients with HCC who underwent curative-intent hepatectomy (2000–2022) were analyzed from a multi-institutional database and categorized by TTS (≤60 or &gt;60 days). Overall survival (OS) and cancer-specific survival were assessed.</div></div><div><h3>Results</h3><div>Among 910 patients, median TTS estimates were 22 days in the short TTS group (n = 485) and 120 days in the long TTS group (n = 425). Patients with long TTS were older and were more likely to have American Society of Anesthesiologists class &gt;2, diabetes mellitus, and cirrhosis. There was no difference in median TBS among patients who had short versus long TTS (4.61 vs 5.00, respectively). In addition, there was no difference in 5-year OS (70.0% vs 63.1%, respectively; <em>P</em> =.05). On multivariate analysis TBS (hazard ratio [HR], 1.07; 95% CI, 1.03–1.11; <em>P</em> &lt;.001), log alpha-fetoprotein (HR, 1.08; 95% CI, 1.01–1.14; <em>P</em> =.02), and albumin-bilirubin score (HR, 2.52; 95% CI, 1.66–3.82; <em>P</em> &lt;.001) were associated with OS. In contrast, TTS was not associated with OS (HR, 1.18; 95% CI, 0.78–1.77; <em>P</em> =.43). Interaction analysis demonstrated that TBS was asssociated with OS among patients with short TTS (HR, 1.12; 95% CI, 1.07–1.17; <em>P</em> &lt;.001), but not among patients with long TTS (HR, 0.98; 95% CI, 0.91–1.05; <em>P</em> =.56). Among patients with low TBS (≤5), higher mortality was observed with long TTS versus short TTS (5-year OS: 82.4% vs 63.0%, respectively; <em>P</em> =.001); however, TTS was not associated with OS among patients with high TBS (5-year OS: 57.9% vs 63.3%, respectively; <em>P</em> =.92). Multivariate analysis demonstrated that long TTS was a risk factor for OS among patients with low TBS (HR, 3.12; 95% CI, 1.60–6.01; <em>P</em> &lt;.001), but not among individuals with high TBS (HR, 0.57; 95% CI, 0.30–1.07; <em>P</em> =.08). Similar trends were observed relative to cancer-specific survival.</div></div><div><h3>Conclusion</h3><div>TTS needs to be considered in light of patient and tumor-specific factors. Expediting TTS may be particularly important among patients with HCC and a low TBS.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"29 2","pages":"Article 101903"},"PeriodicalIF":2.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Gastrointestinal Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1